LOVAZA Drug Patent Profile
✉ Email this page to a colleague
When do Lovaza patents expire, and when can generic versions of Lovaza launch?
Lovaza is a drug marketed by Woodward and is included in one NDA.
The generic ingredient in LOVAZA is omega-3-acid ethyl esters. There are thirteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the omega-3-acid ethyl esters profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lovaza
A generic version of LOVAZA was approved as omega-3-acid ethyl esters by GLW on April 7th, 2014.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LOVAZA?
- What are the global sales for LOVAZA?
- What is Average Wholesale Price for LOVAZA?
Summary for LOVAZA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 6 |
Clinical Trials: | 82 |
Patent Applications: | 222 |
Drug Prices: | Drug price information for LOVAZA |
Drug Sales Revenues: | Drug sales revenues for LOVAZA |
What excipients (inactive ingredients) are in LOVAZA? | LOVAZA excipients list |
DailyMed Link: | LOVAZA at DailyMed |
Recent Clinical Trials for LOVAZA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Prisma Health-Midlands | Phase 2/Phase 3 |
H. Lee Moffitt Cancer Center and Research Institute | Phase 2 |
James and Esther King Biomedical Research Program | Phase 2 |
Paragraph IV (Patent) Challenges for LOVAZA
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
LOVAZA | Capsules | omega-3-acid ethyl esters | 1 g | 021654 | 3 | 2008-11-10 |
US Patents and Regulatory Information for LOVAZA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Woodward | LOVAZA | omega-3-acid ethyl esters | CAPSULE;ORAL | 021654-001 | Nov 10, 2004 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LOVAZA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Woodward | LOVAZA | omega-3-acid ethyl esters | CAPSULE;ORAL | 021654-001 | Nov 10, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Woodward | LOVAZA | omega-3-acid ethyl esters | CAPSULE;ORAL | 021654-001 | Nov 10, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Woodward | LOVAZA | omega-3-acid ethyl esters | CAPSULE;ORAL | 021654-001 | Nov 10, 2004 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LOVAZA
See the table below for patents covering LOVAZA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Austria | 453701 | ⤷ Sign Up | |
World Intellectual Property Organization (WIPO) | 2004007655 | ⤷ Sign Up | |
Denmark | 173371 | ⤷ Sign Up | |
Sweden | 0202188 | ⤷ Sign Up | |
Denmark | 2295529 | ⤷ Sign Up | |
Australia | 2003249109 | A PROCESS FOR DECREASING THE AMOUNT OF CHOLESTEROL IN A MARINE OIL USING A VOLATILE WORKING FLUID | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |